OncoMed Announces Third Quarter 2018 Financial Results and Operational Highlights
ONCOMED PHARMACEUTICALS (OMED)
Last oncomed pharmaceuticals earnings: 11/1 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
oncomed.com/invest/index.cfm
Company Research
Source: GlobeNewswire
-Company continues enrollment in Phase 1b navicixizumab trial following encouraging single agent and interim combination results in ovarian cancer; -Prepares for presentation of etigilimab data at Society for Immunotherapy of Cancer (SITC) Annual Meeting REDWOOD CITY, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced third quarter 2018 financial results and provided a corporate update. As of September 30, 2018, cash, cash equivalents, and short-term investments totaled $70.9 million. "As anticipated, our development efforts have culminated in a stream of data this year and set the stage for additional data flow in 2019,” said John Lewicki, Ph.D., President and Chief Executive Officer of OncoMed. “The efficacy of navicixizumab, both as a single agent and in combination with chemotherapy, has been impressive in patie
Show less
Read more
Impact Snapshot
Event Time:
OMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OMED alerts
High impacting ONCOMED PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics